Connecting Specialists Worldwide
Join us on
LinkedIn, ResearchGate,
Doctorsbook,
Twitter, Facebook,
Google
Groups, YouTube, SlideShare,
Flickr, and
share informations and opinions. Check out Senology.org
Newspaper and follow our RSS
feeds for real-time updates
Literature Selection
Comment
- "Association
between night-work and breast cancer risk",
Johnni Hansen, Institute of Cancer Epidemiology, Danish
Cancer Society, Copenhagen, Denmark
"Our study has the following clinical implications: 1) Overall, this
study further strengths the evidence for an association between
night-work and breast cancer risk. Now, 10 out of 13
epidemiological studies have supported this link, which was
evaluated by the International Agency for Research on Cancer in
2007 as “possibly carcinogenic”. 2)
The breast cancer risk seems minimal, if any, for less
than 3 consecutive night shifts per week. 3) Diurnal preference
seems to be an indicator of breast cancer risk. 4) Especially
women with morning preference should avoid or limit night
shift work. 5) Further studies are needed and ongoing, also in
other potential target organs such as the prostate and
colo-rectal.
"
(Commentary on:
Hansen
J et al.: "Nested case-control study of night
shift work and breast cancer risk among women in the Danish
military", Occup
Environ Med. 2012 [Epub ahead of print])
Calendar of Events
- IBUS
Update in Breast Imaging, 19 - 22 September 2012, Ferrara, Italy
-
12th
Michelangelo Foundation Seminar:
“Moving
from adjuvant to neoadjuvant trials for development of new
therapies in breast cancer: a hopeless heresy or a feasible
paradigm shift?”,
October 12, 2012 Milan,
Italy
- 17th
World Congress on Breast Diseases of the Senologic International
Society, -SIS, October 10-13, 2012, Salvador, Bahia, Brazil
- Breast Cancer in Young Women
Conference, 8-10 November 8-10, 2012,
Dublin, Ireland
-
IBUS
- International Breast Ultrasound Course, 13 - 15 November 2012,
Tel Aviv, Israel
- 8th
Meet the Professor. Advanced International Breast Cancer
Conference (AIBCC), November 15-17, 2012, Padova , Italy - under
the Patronage of Senology.org
- 2012
CTRC-AACR San Antonio Breast Cancer Symposium
, December 4-8, 2012, San Antonio, TX, USA
Literature Selection
- Tavani A
et al.: "Dietary folates and cancer risk in a network of
case-control studies", Ann
Oncol. 2012 Aug 16. [Epub ahead of print]
- Nam JH
et al.: "Association of the interval between endoscopies
with gastric
cancer stage at diagnosis in a region of high prevalence,",
Cancer. 2012 Jul 16.
doi: 10.1002/cncr.27495. [Epub ahead of print]
- de
Vathaire F et al.: "Radiation
dose to the pancreas and risk of diabetes mellitus in childhood
cancer survivors: a retrospective cohort study", Lancet
Oncol. 2012 Aug 22. [Epub ahead of print]
- Levenback
CF et al.: "Lymphatic Mapping and Sentinel Lymph Node
Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A
Gynecologic Oncology Group Study, J
Clin Oncol. 2012 Jul 2. [Epub ahead of print]
- Wilt TJ
et al.: "Radical prostatectomy versus observation for
localized prostate cancer", N
Engl J Med. 2012 Jul 19;367(3):203-13
- Heijnsdijk
EA et al. : "Quality-of-life effects of prostate-specific
antigen screening", N
Engl J Med. 2012 Aug 16;367(7):595-605
- Choe KS
et al.: "Aspirin Use and the Risk of Prostate Cancer
Mortality in Men Treated With Prostatectomy or Radiotherapy",
J
Clin Oncol. 2012 Aug 27. [Epub ahead of print]
- Kunath F
et al.: "Tamoxifen for the management of breast events
induced by non-steroidal antiandrogens in patients with prostate
cancer: A systematic review", BMC
Med. 2012 Aug 28;10(1):96. [Epub ahead of print]
- Petrelli
F et al.: "Risk of venous and arterial thromboembolic
events associated with anti-EGFR agents: a meta-analysis of
randomized clinical trials", Ann
Oncol. 2012 Jul;23(7):1672-9
Fragments of History
Literature Selection
Senology.org
collaborates with TalkAboutHealth.com
- "Cancer questions, answers, and support". Follow the Expert
Q&A Workshops
and join
the conversation.
Q&A
of the month
"Every
patient’s cancer is unique. Two patients with the same type of
cancer will often respond differently to the same treatment.
Tumorgrafts are pieces of living tumor tissue from a specific
patient that are implanted (or grafted) into a mouse. Once the
patients tumor (graft) begins to grow in the mice, it can be
expanded in additional mice and tested against different cancer
drugs. The graft can be used to personalize cancer therapy by
finding the drug or combination of drugs that works best to shrink
the tumor in the mouse. This information can then be used by the
treating physician to personalize the patient’s cancer care
."
(Answer by
David Sidransky,
Johns
Hopkins Hospital,
Baltimore, MD USA)
Next Q&A Workshops
- "Neuro-
Oncology", with Lawrence Recht, Stanford
Cancer Institute, September
10, 2012
- "Uveal
melanoma", with William Harbour, University
of Miami, September 11, 2012
|